Webinar: Curbing the Opioid Crisis: The Role of the Clinical Laboratory for Pain Management

Speaker: Alan Wu, Ph.D
Professor Laboratory Medicine; Chief, Clinical Chemistry Laboratory, SFGH; Chief, Clinical Pharmacogenomics Laboratory, University of California San Francisco

In this webinar you will learn about the history and depth of the Opioid Crisis and the importance of the clinical laboratory in the patient continuum. In addition, you will learn to understand the important advantages of using urine drug-screening technology to eliminate cross-reactivity with other drugs, the benefits of oral fluid testing, and the role of LC-MS for confirmation testing of urine and oral fluids.

This webinar was hosted by AACC and sponsored by Thermo Fisher Scientific

Alan Wu, Ph.D. Biography

Dr. Alan H.B. Wu received a B.S. in both Chemistry and Biology at Purdue University and a Ph.D. in Analytical Chemistry at the University of Illinois. He was a professor at the University of Texas and the University of Connecticut prior to his current position as a Professor of Laboratory Medicine at the University of California, San Francisco. He is the Section Chief of Clinical Chemistry, Toxicology and Pharmacogenomics at San Francisco General Hospital.

Email Address

First Name

Last Name

Job Title

Institution

City

Zip or Postal Code

*Required field

Learn more and stay informed.

I would like to learn more about Drugs of Abuse Testing Assays. Please have a Thermo Fisher Scientific representative contact me.

To ensure that we are complying with your preferences, we need to confirm permission to send you communications by email.

I would like to receive emails about relevant Thermo Fisher Scientific™ information and promotions. By selecting this option, you are acknowledging that you have read and understand our Privacy Policy.